NCT03156985 - Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China | Biotech Hunter

Enrollment

3,000

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions

Type 2 Diabetes Mellitus

Trial Locations (83)

0

Research Site, Hohhot

Research Site, Kunshan

Research Site, Taiyuan

Research Site, Tianjin

100028

Research Site, Beijing

100043

Research Site, Beijing

100054

Research Site, Beijing

100062

Research Site, Beijing

100076

Research Site, Beijing

100078

Research Site, Beijing

100080

Research Site, Beijing

100095

Research Site, Beijing

100123

Research Site, Beijing

100730

Research Site, Beijing

102500

Research Site, Beijing

110000

Research Site, Shengyang

116003

Research Site, Dalian

200120

Research Site, Shanghai

210000

Research Site, Nanjing

211100

Research Site, Nanjing

215300

Research Site, Kunshan

221005

Research Site, Xuzhou

221009

Research Site, Xuzhou

222023

Research Site, Lianyungang

224000

Research Site, Yancheng

226200

Research Site, Nantong

Research Site, Qidong

230011

Research Site, Hefei

232001

Research Site, Huainan

243000

Research Site, Maanshan

250000

Research Site, Jinan

255020

Research Site, Zibo

261000

Research Site, Weifang

261400

Research Site, Laizhou

266000

Research Site, Qingdao

300052

Research Site, Tianjin

300140

Research Site, Tianjin

300450

Research Site, Tianjin

310006

Research Site, Hangzhou

315010

Research Site, Ningbo

315020

Research Site, Ningbo

317500

Research Site, Wenling

325000

Research Site, Wenzhou

325200

Research Site, Ruian

400014

Research Site, Chongqing

408000

Research Site, Chongqing

410006

Research Site, Changsha

410200

Research Site, Changsha

410300

Research Site, Guankou

430015

Research Site, Wuhan

430022

Research Site, Wuhan

450014

Research Site, Zhengzhou

453000

Research Site, Xingxiang

458000

Research Site, Shijiazhuang

510075

Research Site, Guangzhou

510150

Research Site, Guangzhou

510811

Research Site, Guangzhou

510900

Research Site, Guangzhou

513061

Research Site, Yingcheng

516002

Research Site, Huizhou

518005

Research Site, Shenzhen

518052

Research Site, Shenzhen

518101

Research Site, Shenzhen

518119

Research Site, Shenzhen

519001

Research Site, Zhuhai

519099

Research Site, Zhuhai

523073

Research Site, Dongguan

523413

Research Site, Dongguan

524045

Research Site, Zhanjiang

526040

Research Site, Zhaoqing

528251

Research Site, Foshan

541002

Research Site, Guilin

541003

Research Site, Guilin

550005

Research Site, Guiyang

637000

Research Site, Nanchong

650204

Research Site, Kunming

710000

Research Site, Xi'an

710054

Research Site, Xi'an

710100

Research Site, Xi'an

730000

Research Site, Lanzhou

730030

Research Site, Lanzhou

810000

Research Site, Xining

830000

Research Site, Ürümqi